BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17351321)

  • 1. Diagnostic value of the Reflux Disease Questionnaire in general practice.
    Aanen MC; Numans ME; Weusten BL; Smout AJ
    Digestion; 2006; 74(3-4):162-8. PubMed ID: 17351321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
    Dent J; Vakil N; Jones R; Bytzer P; Schöning U; Halling K; Junghard O; Lind T
    Gut; 2010 Jun; 59(6):714-21. PubMed ID: 20551454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Reflux Disease Questionnaire (RDQ) and Gastrointestinal Impact Scale (GIS) in patients with gastroesophageal reflux disease in the Spanish population].
    Nuevo J; Tafalla M; Zapardiel J
    Gastroenterol Hepatol; 2009 Apr; 32(4):264-73. PubMed ID: 19371971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.
    van Zanten SV; Armstrong D; Barkun A; Junghard O; White RJ; Wiklund IK
    Aliment Pharmacol Ther; 2007 May; 25(9):1087-97. PubMed ID: 17439510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
    Pace F; Negrini C; Wiklund I; Rossi C; Savarino V;
    Aliment Pharmacol Ther; 2005 Aug; 22(4):349-56. PubMed ID: 16098002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric validation of the Hungarian translation of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with reflux disease.
    Kulich RK; Ujszászy L; Tóth GT; Bárány L; Carlsson J; Wiklund I
    Orv Hetil; 2004 Mar; 145(13 Suppl 2):723-9, 739-44. PubMed ID: 15125325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.
    Dent J; Kahrilas PJ; Hatlebakk J; Vakil N; Denison H; Franzén S; Lundborg P
    Am J Gastroenterol; 2008 Jan; 103(1):20-6. PubMed ID: 18184117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments.
    Talley NJ; Fullerton S; Junghard O; Wiklund I
    Am J Gastroenterol; 2001 Jul; 96(7):1998-2004. PubMed ID: 11467624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Am J Gastroenterol; 2012 Sep; 107(9):1354-60. PubMed ID: 22777339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2007; 75 Suppl 1():69-78. PubMed ID: 17489035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?
    Rey E; Barceló M; Zapardiel J; Sobreviela E; Muñoz M; Díaz-Rubio M
    BMC Gastroenterol; 2014 Jan; 14():17. PubMed ID: 24450939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
    Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
    Digestion; 2007; 75 Suppl 1():62-8. PubMed ID: 17489034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.
    van Zanten SV; Wahlqvist P; Talley NJ; Halling K; Vakil N; Lauritsen K; Flook N; Persson T; Bolling-Sternevald E;
    Aliment Pharmacol Ther; 2011 Oct; 34(7):714-23. PubMed ID: 21848799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD).
    Wiklund IK; Junghard O; Grace E; Talley NJ; Kamm M; Veldhuyzen van Zanten S; Paré P; Chiba N; Leddin DS; Bigard MA; Colin R; Schoenfeld P
    Eur J Surg Suppl; 1998; (583):41-9. PubMed ID: 10027672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux.
    Orenstein SR; McGowan JD
    J Pediatr; 2008 Mar; 152(3):310-4. PubMed ID: 18280832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.